Total Payments
$9,498
2024 Payments
$545.31
Companies
48
Transactions
359
Medicare Patients
453
Medicare Billing
$79,059
Payment Breakdown by Category
Food & Beverage$6,014 (63.3%)
Education$3,299 (34.7%)
Travel$185.42 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,014 | 353 | 63.3% |
| Education | $3,299 | 4 | 34.7% |
| Travel and Lodging | $185.42 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,477 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,015 | 76 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $585.14 | 34 | $0 (2023) |
| Allergan, Inc. | $354.66 | 21 | $0 (2020) |
| United Therapeutics Corporation | $353.58 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $324.91 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $315.33 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $312.00 | 17 | $0 (2024) |
| ABBVIE INC. | $243.67 | 14 | $0 (2024) |
| Insmed, Inc. | $201.97 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $545.31 | 29 | GlaxoSmithKline, LLC. ($103.91) |
| 2023 | $776.44 | 45 | GlaxoSmithKline, LLC. ($272.71) |
| 2022 | $4,040 | 35 | Intuitive Surgical, Inc. ($3,477) |
| 2021 | $306.61 | 18 | Actelion Pharmaceuticals US, Inc. ($106.26) |
| 2020 | $331.22 | 21 | Merck Sharp & Dohme Corporation ($66.86) |
| 2019 | $975.65 | 64 | GlaxoSmithKline, LLC. ($119.92) |
| 2018 | $1,082 | 65 | GlaxoSmithKline, LLC. ($179.65) |
| 2017 | $1,441 | 82 | GlaxoSmithKline, LLC. ($166.71) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Airway Clearance Device | ||||||
| 09/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/19/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 05/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Oncology | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 99 | 127 | $43,900 | $11,533 |
| 2022 | 8 | 109 | 168 | $60,110 | $18,214 |
| 2021 | 6 | 129 | 187 | $66,315 | $23,875 |
| 2020 | 3 | 116 | 187 | $71,905 | $25,437 |
Total Patients
453
Total Services
669
Medicare Billing
$79,059
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 32 | $13,600 | $3,446 | 25.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 27 | $6,480 | $2,272 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,620 | $2,080 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 26 | $7,510 | $2,035 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,170 | $1,440 | 27.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 11 | 11 | $3,520 | $260.72 | 7.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 50 | $26,250 | $8,360 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 23 | $5,635 | $3,058 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $5,525 | $1,650 | 29.9% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2022 | 11 | 11 | $12,650 | $1,568 | 12.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 19 | $3,800 | $1,479 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 20 | $3,300 | $1,428 | 43.3% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2022 | 11 | 11 | $1,760 | $565.08 | 32.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 11 | 17 | $1,190 | $104.25 | 8.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 32 | 72 | $37,800 | $12,173 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 35 | $7,000 | $2,777 | 39.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 26 | 26 | $8,450 | $2,718 | 32.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 17 | $4,165 | $2,360 | 56.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $4,940 | $1,998 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 24 | $3,960 | $1,849 | 46.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 43 | 89 | $46,725 | $15,077 | 32.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 67 | $13,400 | $5,465 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 31 | $11,780 | $4,895 | 41.6% |
About Dr. John Callison, MD
Dr. John Callison, MD is a Emergency Medical Services healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528115334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Callison, MD has received a total of $9,498 in payments from pharmaceutical and medical device companies, with $545.31 received in 2024. These payments were reported across 359 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,014).
As a Medicare-enrolled provider, Callison has provided services to 453 Medicare beneficiaries, totaling 669 services with total Medicare billing of $79,059. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medical Services
- Other Specialties Internal Medicine, Student in an Organized Health Care Education/Training Program
- Location Knoxville, TN
- Active Since 01/04/2007
- Last Updated 04/20/2022
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1528115334
Products in Payments
- ION (Device) $3,250
- TRELEGY ELLIPTA (Drug) $502.50
- AVYCAZ (Drug) $338.14
- ZERBAXA (Drug) $288.25
- UPTRAVI (Drug) $271.21
- NUCALA (Biological) $262.66
- Da Vinci Surgical System (Device) $226.54
- STIOLTO RESPIMAT (Drug) $205.02
- Arikayce (Drug) $201.97
- TYVASO (Drug) $177.64
- ORENITRAM (Drug) $175.94
- OPSUMIT MACITENTAN (Drug) $172.92
- SMARTVEST (Device) $167.49
- VIBATIV (Drug) $146.96
- Prolastin-C (Biological) $145.37
- ANORO (Drug) $141.35
- OPSUMIT (Drug) $141.01
- ZENPEP (Drug) $112.60
- XOLAIR (Biological) $107.85
- Xolair (Biological) $95.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.